Company: ADPT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103752
Chunk: 21

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 21
---
independent” as defined in Nasdaq rules. Following the 2025 Annual Meeting, Robert Hershberg, PhD, MD will replace Dr. Pellini on the nominating and corporate governance committee. The nominating and corporate governance committee’s responsibilities include:

| • |     | Developing and recommending to the board of directors criteria for board and committee membership, including the formal set of board nomination and service qualifications adopted in 2023 and shared under “Our Criteria for Board Nomination and Service” above. |

| • |     | Establishing procedures for identifying and evaluating board of director candidates, including nominees recommended by shareholders. |

| • |     | Reviewing the composition of the board of directors to ensure that it is composed of members containing the appropriate skills and expertise to advise us. |

| • |     | Identifying and screening individuals qualified to become members of the board of directors. |

| • |     | Recommending to the board of directors the persons to be nominated for election as directors and to each of the board’s committees. |

| • |     | Developing and recommending to the board of directors a code of business conduct and ethics and a set of corporate governance guidelines. |

| • |     | Overseeing the evaluation of our board of directors and management. |

The nominating and corporate governance committee will consider director candidates recommended by shareholders on the same basis that it evaluates other nominees for director. Shareholders who wish to recommend a candidate to our nominating and corporate governance committee for consideration for nomination should send to us, at our principal executive offices, information regarding the candidate. In order to identify potential director candidates, the committee may utilize its or our existing networks or retain a third-party recruiting firm. Compensation and Human Capital Committee Interlocks and Insider Participation As noted above, Robert Hershberg, PhD, MD, Peter Neupert and Katey Owen, PhD served as members of our compensation and human capital committee during 2024. During 2024, none of the members of our compensation and human capital committee were officers or employees or had a relationship requiring disclosure under “ Relationships and Related Party Transactions.” None of our executive officers currently serves, nor in the past year has served, as a member of the board of directors or compensation and human capital committee of any entity that has one or more executive officers serving on our board of directors or compensation and human capital committee. Insider Trading Policy We have adoptedan insider trading policy that applies to our employees, directors, officers, and consultants, their family members and entities over which such individuals